PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.38%
Revenue growth below 50% of CRON.TO's 18.36%. Michael Burry would check for competitive disadvantage risks.
-90.81%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
44.31%
Similar gross profit growth to CRON.TO's 48.26%. Walter Schloss would investigate industry dynamics.
48.17%
Margin expansion exceeding 1.5x CRON.TO's 25.26%. David Dodd would verify competitive advantages.
-50.01%
R&D reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine competitive risk.
-27.45%
G&A reduction while CRON.TO shows 64.47% growth. Joel Greenblatt would examine efficiency advantage.
-20.71%
Marketing expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine competitive risk.
31.32%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-24.61%
Operating expenses reduction while CRON.TO shows 36.47% growth. Joel Greenblatt would examine advantage.
-46.09%
Total costs reduction while CRON.TO shows 1.22% growth. Joel Greenblatt would examine advantage.
-64.91%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-9.32%
D&A reduction while CRON.TO shows 17.05% growth. Joel Greenblatt would examine efficiency.
463.83%
EBITDA growth exceeding 1.5x CRON.TO's 68.19%. David Dodd would verify competitive advantages.
148.36%
EBITDA margin growth exceeding 1.5x CRON.TO's 42.10%. David Dodd would verify competitive advantages.
143.07%
Operating income growth below 50% of CRON.TO's 632.73%. Michael Burry would check for structural issues.
141.66%
Operating margin growth below 50% of CRON.TO's 550.11%. Michael Burry would check for structural issues.
-184.88%
Other expenses reduction while CRON.TO shows 110.16% growth. Joel Greenblatt would examine advantage.
-151.50%
Pre-tax income decline while CRON.TO shows 137.06% growth. Joel Greenblatt would examine position.
-149.81%
Pre-tax margin decline while CRON.TO shows 100.29% growth. Joel Greenblatt would examine position.
113.03%
Tax expense growth less than half of CRON.TO's 615.76%. David Dodd would verify if advantage is sustainable.
-154.14%
Net income decline while CRON.TO shows 85.00% growth. Joel Greenblatt would examine position.
-152.37%
Net margin decline while CRON.TO shows 56.31% growth. Joel Greenblatt would examine position.
-148.34%
EPS decline while CRON.TO shows 23.46% growth. Joel Greenblatt would examine position.
-145.86%
Diluted EPS decline while CRON.TO shows 23.46% growth. Joel Greenblatt would examine position.
23.88%
Share count reduction below 50% of CRON.TO's 16.41%. Michael Burry would check for concerns.
23.19%
Diluted share reduction below 50% of CRON.TO's 9.38%. Michael Burry would check for concerns.